Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds

Correction of Nasolabial Folds Clinical Trial

Official title:
A Prospective, Open Label, Dose-escalating, Multicenter Clinical Investigation to Evaluate the Safety and Effectiveness of THIODERM STRONG in the Correction of Nasolabial Folds.

Status Completed

Clinical Trial Summary

This is a prospective, open label, dose-escalating, multicenter clinical investigation to evaluate the safety and effectiveness of THIODERM STRONG in the correction of nasolabial folds.

The performance is assessed using the 5-point Nasolabial Folds Severity Rating Scale (NLF-SRS) at Week 12 compared to baseline.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Correction of Nasolabial Folds

Clinical Trial Details

NCT number	NCT03650218
Study type	Interventional
Source	Croma-Pharma GmbH
Contact
Status	Completed
Phase	N/A
Start date	July 10, 2018
Completion date	December 23, 2019

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02334358` - Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Classic s
Completed	`NCT03611491` - Post Market Study Evaluating Princess Filler Lidocaine for the Correction of Nasolabial Folds	N/A
Completed	`NCT05106751` - A Randomized, Multicenter, Evaluator-Blinded, Active-Controlled, Parallel-Group Investigation to Evaluate the Performance and Safety of YVOIRE® Classic Plus Versus Comparator for Temporary Correction of Nasolabial Folds	Phase 4
Completed	`NCT02661737` - Observational Study to Evaluate Long-term Safety and Biodegradability of YVOIRE Volume s
Completed	`NCT02179606` - Clinical Study to Evaluate the Efficacy and Safety of Dermalax Implant Plus	Phase 3
Completed	`NCT05235126` - A Clinical Investigation of the Decoria® Aesthetic Group (DAG) for Correction of Nasolabial Folds (NLF)	N/A
Completed	`NCT02179619` - Clinical Study to Evaluate the Efficacy and Safety of Dermalax(Deep) in Correction of Nasolabial Folds	Phase 3
Unknown status	`NCT01492140` - Injection Assistance Device Versus Manual Injections for Delivery of Dermal Fillers	Phase 4